| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.4B | $21.0B | $21.4B | $23.7B | $20.8B | $5.0B | $4.5B | $4.1B |
| Cost of Revenue | $17.6B | $16.4B | $16.7B | $19.1B | $17.3B | $15.3B | $15.0B | $13.5B |
| Gross Profit | $4.9B | $4.6B | $4.7B | $4.7B | $3.6B | $0.9B | $0.8B | $0.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $3.2B | $3.0B | $3.0B | $3.0B | $2.1B | $2.0B | $1.7B | $1.5B |
| Operating Income | $1.7B | $1.7B | $1.7B | $1.7B | $1.4B | $0.3B | $0.3B | $0.2B |
| Net Income | $1.1B | $1.1B | $1.1B | $1.1B | $1.0B | $0.2B | $0.2B | $0.2B |
| EPS (Basic) | $8.13 | $8.06 | $8.20 | $8.24 | $7.14 | $1.67 | $1.29 | $1.07 |
| EPS (Diluted) | $8.08 | $7.97 | $8.10 | $8.13 | $7.04 | $1.65 | $1.27 | $1.05 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.0B | $14.7B | $13.3B | $13.1B | $13.2B | $9.3B | $8.0B | $7.2B |
| Current Assets | $8.5B | $7.4B | $6.7B | $6.6B | $6.5B | $6.0B | $4.3B | $3.8B |
| Cash & Equivalents | $0.6B | $0.5B | $0.6B | $0.3B | $0.3B | $1.4B | $0.2B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | $6.0B |
| Current Liabilities | $7.2B | $5.5B | $5.4B | $4.9B | $5.1B | $3.9B | $3.5B | $2.8B |
| Stockholders' Equity | $2.6B | $2.4B | $2.0B | $1.6B | $0.7B | $1.3B | $1.0B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.3B | $1.6B | $1.3B | $0.8B | $1.3B | $1.0B | $0.9B |
| Investing Cash Flow | $0.1B | $-0.7B | $-0.2B | $-0.2B | $-2.8B | $-0.2B | $-0.3B | $-0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | $0.1B |
| Financing Cash Flow | $-1.2B | $-0.7B | $-1.1B | $-1.1B | $0.8B | $0.1B | $-0.7B | $-0.8B |